| Serial Number | 97728483 |
| Word Mark | CANCER MARS SHOT FIGHTING CANCER TOGETHER |
| Filing Date | Thursday, December 22, 2022 |
| Status | 774 - OPPOSITION PENDING |
| Status Date | Wednesday, July 10, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, March 12, 2024 |
| Description of Mark | The mark consists of the words "CANCER MARS SHOT" across the middle with "FIGHTING CANCER TOGETHER" centered below it, with a semi-circle above and below the words of jagged lines similar to the depiction of an EEG or EKG. |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| NOT AVAILABLE | "CANCER" |
| Goods and Services | Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; conducting scientific research and scientific research in the nature of conducting clinical trials in the field of oncology and cancer research for others; Providing a website featuring educational information in the field of clinical research; Medical and scientific research, namely, conducting clinical trials for others; Providing medical testing services and information in the field of cancer research and disease classification; technical research and consulting in the field of pharmaceutical studies; Pharmaceutical research services; Pharmaceutical research and development; testing of pharmaceuticals; Biotechnology research; Medical research; DNA analysis services for scientific research purposes; Medical and scientific research in the field of molecular profiling and biomarker discovery in cancer patients; Medical and scientific research in the field of cancer treatment; Providing medical research information in the nature of medical research data pertaining to cancer and its treatment; consulting services for others in the field of project Management of clinical and translational trials in the field of cancer treatment for others in the nature of conducting clinical trials for others; Providing medical and scientific research in formation from clinical trials in the nature of research data pertaining to cancer; consulting services for others in the field of design, planning and implementation of clinical trials, specifically thedevelopment and validation of clinical trials and testsper formed during clinical trials; testing, analysis and evaluation of the clinical trials and tests of others to determine conformity with certification standards; Design,research, development and testing servicesin the field of pharmaceuticals, biobanking, and cancer research for medical and scientific purposes; Preclinical scientific and medical research services in the field of biospecimens collections; Research in the field of artificial intelligence for medical and scientific research purposes |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 19, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Wednesday, December 21, 2022 |
| First Use In Commerce Date | Wednesday, December 21, 2022 |
| Party Name | Audubon Health Group, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Houston, TX 77021 |
| Party Name | Audubon Health Group, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Houston, TX 77021 |
| Event Date | Event Description |
| Monday, December 26, 2022 | NEW APPLICATION ENTERED |
| Thursday, January 19, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 20, 2023 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Friday, September 22, 2023 | ASSIGNED TO EXAMINER |
| Monday, January 8, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, January 8, 2024 | NON-FINAL ACTION E-MAILED |
| Monday, January 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, February 5, 2024 | EXAMINERS AMENDMENT -WRITTEN |
| Monday, February 5, 2024 | EXAMINERS AMENDMENT E-MAILED |
| Monday, February 5, 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Monday, February 5, 2024 | EXAMINER'S AMENDMENT ENTERED |
| Monday, February 5, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 21, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 12, 2024 | PUBLISHED FOR OPPOSITION |
| Wednesday, February 21, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 12, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, April 10, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, July 10, 2024 | OPPOSITION INSTITUTED NO. 999999 |
| Wednesday, July 10, 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |